A Stanford University spinout that lists Johnson & Johnson, Novartis and Pfizer among its users has raised $10 million to develop its brain mapping…

Trialbee has added ex-Lundbeck CEO Ulf Wiinberg and former Bristol-Myers Squibb SVP Lars Birgerson to its board of directors.

Apple has bought three-year-old startup Gliimpse to build out its health data capabilities.

The rise of genome sequencing has opened a new frontier for the issue that could drive divergence of the cancer care received by different races.

The Pfizer study that identified 15 genome sites linked to depression in 23andMe’s database has sparked a surge in demands to access the repository.

Researchers have enrolled 2,000 people with metastatic breast cancer in 7 months using a social media-enabled, direct-to-patient model of recruiting.

Google's Art Levinson-helmed biotech Calico has hired Daphne Koller to build and lead its computational biology and machine learning team.

Synthego has emerged from stealth mode equipped with guide RNA products for use in CRISPR/Cas9 genome engineering.